SE0602446L - New use of known pharmacologically active chemical compositions - Google Patents

New use of known pharmacologically active chemical compositions

Info

Publication number
SE0602446L
SE0602446L SE0602446A SE0602446A SE0602446L SE 0602446 L SE0602446 L SE 0602446L SE 0602446 A SE0602446 A SE 0602446A SE 0602446 A SE0602446 A SE 0602446A SE 0602446 L SE0602446 L SE 0602446L
Authority
SE
Sweden
Prior art keywords
pharmacologically active
chemical compositions
new use
active chemical
alpha
Prior art date
Application number
SE0602446A
Other languages
Swedish (sv)
Inventor
Stefan Pierzynowski
Original Assignee
Entress Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entress Ab filed Critical Entress Ab
Priority to SE0602446A priority Critical patent/SE0602446L/en
Priority to PCT/EP2007/062333 priority patent/WO2008058993A2/en
Publication of SE0602446L publication Critical patent/SE0602446L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to Use of at least one member selected from the group consisting of alpha-ketoglutaric acid (AKG)5 pharmaceutically acceptable salts of alpha-ketoglutaric acid and amides of alpha-ketoglutaric acid for the manufacture of a pharmaceutical preparation or a food or feed supplement for the treatment or prophylaxis of diseases related to infection of pathogenic strains of Helicobacter pylori in birds and mammals, including man.
SE0602446A 2006-11-16 2006-11-16 New use of known pharmacologically active chemical compositions SE0602446L (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0602446A SE0602446L (en) 2006-11-16 2006-11-16 New use of known pharmacologically active chemical compositions
PCT/EP2007/062333 WO2008058993A2 (en) 2006-11-16 2007-11-14 Use of alpha ketogluaric acid for the treatment of infection with h. pylori

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0602446A SE0602446L (en) 2006-11-16 2006-11-16 New use of known pharmacologically active chemical compositions

Publications (1)

Publication Number Publication Date
SE0602446L true SE0602446L (en) 2008-05-17

Family

ID=38814302

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0602446A SE0602446L (en) 2006-11-16 2006-11-16 New use of known pharmacologically active chemical compositions

Country Status (2)

Country Link
SE (1) SE0602446L (en)
WO (1) WO2008058993A2 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919855B1 (en) * 1970-10-06 1974-05-21
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
SE0200256D0 (en) * 2001-12-21 2002-01-29 Gramineer Internat Ab New composition, methods and use
JP4880477B2 (en) * 2004-10-20 2012-02-22 壽製薬株式会社 Pharmaceutical composition for the treatment of gastric mucosal disease
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
KR20080102372A (en) * 2006-01-19 2008-11-25 엔트레스 에이비 Method of diagnosis and method of treatment
PL226695B1 (en) * 2006-07-03 2017-08-31 Danuta Kruszewska Agent for preventing and/or inhibiting the colonization of Helicobater pylori and its application

Also Published As

Publication number Publication date
WO2008058993A3 (en) 2008-11-20
WO2008058993A2 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
MA33467B1 (en) Primary drugs include insulin-linking facilities
MX2012007410A (en) Novel antiviral compounds.
MX2011012122A (en) Thiophene derivatives.
UA108363C2 (en) IMINOTIADIASIADIOXIDE OXIDES AS BACE INHIBITORS, COMPOSITIONS THEREOF AND THEIR APPLICATIONS
SG166115A1 (en) Pharmaceutical preparation containing meloxicam
UY32599A (en) ABT-263 SOLID ORAL FORMULATION
UA105229C2 (en) Pharmaceutical formulation
BRPI0414581A (en) benzimidazole derivatives: preparation and pharmaceutical applications
MY158974A (en) Prodrugs comprising an exendin linker conjugate
NO20043367L (en) Oral pharmaceutical preparation
UA110013C2 (en) APPLICATION OF THE COMPOSITION FOR THE TREATMENT OF BALL-MARI-HERE AND THE RELATED DISORDERS
MX344787B (en) Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders.
UA93393C2 (en) 1,3-dioxane carboxylic acids
IL193252A0 (en) N-hydroxyacrylamide compounds
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
SG178975A1 (en) Indenone derivative and pharmaceutical composition comprising same
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
EA201001108A1 (en) TABLETS DISPENSABLE IN THE Mouth OF THE TABLET, CONTAINING THE BASIS OF THE ESCITALOPRAM, AND METHOD OF THEIR RECEIVING
MX2009008463A (en) Bioavailable formulations of heterocyclic compounds.
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
TW200728281A (en) Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
BR0311642A (en) Increased Release Sodium Divalproex Formulation
EA201101622A1 (en) PEPTIDE PHARMACEUTICAL COMPOSITION, MEANS ON ITS BASIS FOR THE TREATMENT OF GASTRODUODENAL DISEASES CAUSED BY HELICOBACTER PYLORI, AND A METHOD OF ITS USE
MA32722B1 (en) GALENIC FORMULATION COMPRISING ALISKIRENE AND ASSOCIATED PREPARATION METHOD BY FUSION-EXTRUSION GRANULATION

Legal Events

Date Code Title Description
NAV Patent application has lapsed